In today’s briefing:
- Waste Management Company: Key Drivers
- Bio-Techne Corporation: Expansion RNAscope & Other Drivers
- DXC Technology: Key Drivers
- Novartis AG: Major Drivers
- Qorvo Inc: Key Drivers, Financial Forecasts, DCF & Comparables Valuation, ESG & Other Risks (02/23)
- REPT BATTERO Energy Pre-IPO – The Negatives – Is Only Now Aiming for Sustainable Profits
Waste Management Company: Key Drivers
- Waste Management delivered a highly disappointing result in the last quarter and did not live up to analyst expectations with respect to revenues as well as earnings.
- They observed a slowdown in the rate of labor increases and remained committed to managing operating costs and bending costs to match shifting volumes.
- The company advanced its planned recycling investments and provided more details in the supplemental presentation on its website.
Bio-Techne Corporation: Expansion RNAscope & Other Drivers
- Bio-Techne delivered a disappointing result in the last quarter while failing to meet Wall Street expectations in terms of revenues as well as earnings.
- The company also noticed the strongest effects of decreasing biotech spending in Q2 in North America.
- The multiyear growth rates in North America remain in double digits and are consistent with its long-term objectives.
DXC Technology: Key Drivers
- DXC achieved a decent set of results with strong bookings resulting in $3.57 billion in revenues meeting Wall Street expectations.
- Their organic revenue increased for the second consecutive quarter and the company delivered an earnings beat.
- DXC continues to increase margins and stabilize revenue in GIS.
Novartis AG: Major Drivers
- Novartis delivered a mixed set of results for the last quarter as it failed to meet the revenue expectations of Wall Street but managed an earnings beat.
- The management continued to invest in the organic business, pursued value-creating bolt-ons, and looked at the full range of M&A opportunities.
- To further extend their opportunities in gene therapy, they acquired PPY, their gene treatment for geographic atrophy in ophthalmology.
Qorvo Inc: Key Drivers, Financial Forecasts, DCF & Comparables Valuation, ESG & Other Risks (02/23)
- Qorvo delivered a strong set of results and managed an all-around beat.
- Its power business in particular, reported a successful quarter with active design work for its silicon carbide power products.
- For WiFi products in their Connectivity and Sensors Group, the third quarter showed decreased end-market demand and channel inventory consumption.
REPT BATTERO Energy Pre-IPO – The Negatives – Is Only Now Aiming for Sustainable Profits
- REPT BATTERO Energy (REPT HK) is looking to raise US$1bn in its upcoming Hong Kong IPO.
- REPT BATTERO Energy (REPT) is a lithium-ion battery manufacturer in China, focusing on R&D, production, and sales of EV/ESS lithium-ion battery products such as battery cells, modules and packs.
- In this note, we will talk about the not-so-positive aspects of the deal.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Data and News
- ✓ Events & Webinars
